GlassScriptPhysician profile
Jason Aulffo
NPI 1427390772
$1,805.27
in general payments reported to CMS, 2019-2025
20 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $78.94 · 2022: $188 · 2023: $826 · 2024: $506 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,538.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $494.20 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $279.66 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $168.64 | 2021-2025 | |
| Philips North America LLC | $141.46 | 2022-2025 | (5050) Extended Holter, Extended Holter, (5044) Mcot |
| Pfizer INC. | $126.27 | 2022-2025 | |
| Amgen INC. | $110.25 | 2023-2025 | Repatha |
| Glaxosmithkline, LLC. | $85.46 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boston Scientific Corporation | $53.68 | 2023-2025 | Cds - Mct/Cem Monitoring, Watchman Access System |
| Regeneron Healthcare Solutions, INC. | $49.21 | 2023-2024 | Dupixent |
| Genzyme Corporation | $46.33 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $45.15 | 2021-2023 | Verquvo |
| Altathera Pharmaceuticals LLC | $33.98 | 2024 | Sotalol Hydrochloride |
| Inspire Medical Systems, INC. | $32.23 | 2024-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $31.56 | 2023 | |
| W. L. Gore & Associates, INC. | $29.64 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $18.83 | 2025 | Ohtuvayre |
| Lantheus Medical Imaging, INC. | $17.24 | 2023 | Definity |
| Teva Pharmaceuticals USA, INC. | $15.78 | 2022 | |
| Harmony Biosciences LLC | $13.99 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Aulffo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.